Clinic
Owosso Medical Group, PC
Owosso Medical Group, PC was paid $1.56M by Medicaid between Jan 2018 and May 2024, across 58 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 38% of everything it billed.
33Billing provider infoOWOSSO MEDICAL GROUP, PC
OWOSSO, MI 48867
OWOSSO, MI 48867
33aNPI1023105418assigned 10/06/2006
33bProvider typeMulti-Specialty Clinic/Center
28Total paid$1.56M
24GClaims96,008
24DCodes billed58
24AFirst – last monthJan 2018 – May 2024
Compared with peers
Next to other Multi-Specialty Clinic/Center providers in Michigan
Rank by total paid#11 of 44
Median peer was paid$362K
This provider vs. median4.3×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 4,268 | $149K | |
| 2019 | 7,039 | $178K | |
| 2020 | 8,323 | $140K | |
| 2021 | 13,723 | $242K | |
| 2022 | 18,660 | $300K | |
| 2023 | 34,691 | $403K | |
| 2024incomplete | 9,304 | $145K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 38% | 13,552 | 12,350 | $593K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 30% | 7,753 | 6,990 | $461K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 8.8% | 2,315 | 2,291 | $136K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | 5.6% | 2,691 | 2,369 | $87K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 4.6% | 787 | 785 | $72K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 2.3% | 949 | 924 | $36K |
| 17110 | 1.7% | 414 | 309 | $27K | |
| 94060 | 1.4% | 851 | 830 | $22K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 1.0% | 1,837 | 1,676 | $16K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 565 | 517 | $15K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 1,015 | 982 | $12K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 792 | 762 | $12K |
46 more codes
| 94729 | <1% | 380 | $11K | |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 121 | $9K |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | <1% | 27 | $9K |
| 94010 | <1% | 475 | $6K | |
| 94727 | <1% | 267 | $6K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 391 | $4K |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 835 | $4K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 268 | $3K |
| 94726 | <1% | 84 | $2K | |
| 81002 | <1% | 766 | $2K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 74 | $2K |
| 36415 | Collection of venous blood by venipuncture | <1% | 460 | $2K |
| 99441 | <1% | 118 | $2K | |
| 99406 | <1% | 228 | $2K | |
| 96127 | <1% | 337 | $782.23 | |
| 99201 | <1% | 30 | $720.10 | |
| 11102 | <1% | 12 | $611.21 | |
| 80053 | Comprehensive metabolic panel | <1% | 129 | $576.01 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 392 | $530.15 |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 54 | $340.50 |
| 80061 | Lipid panel | <1% | 46 | $178.01 |
| J1040 | Injection, methylprednisolone acetate, 80 mg | <1% | 18 | $171.78 |
| 99442 | <1% | 14 | $154.50 | |
| 90688 | <1% | 14 | $140.04 | |
| 87807 | <1% | 12 | $120.22 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 13 | $81.90 |
| 88738 | <1% | 25 | $24.96 | |
| 3008F | 0% | 4,449 | $0.00 | |
| 1034F | 0% | 1,646 | $0.00 | |
| 3079F | 0% | 2,573 | $0.00 | |
| 1036F | 0% | 7,500 | $0.00 | |
| 3074F | 0% | 6,424 | $0.00 | |
| 3075F | 0% | 1,771 | $0.00 | |
| 3080F | 0% | 499 | $0.00 | |
| 3044F | 0% | 15 | $0.00 | |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | 0% | 138 | $0.00 |
| G8432 | Depression screening not documented, reason not given | 0% | 41 | $0.00 |
| G8433 | Screening for depression not completed, documented patient or medical reason | 0% | 173 | $0.00 |
| 1159F | 0% | 11,647 | $0.00 | |
| 3078F | 0% | 5,879 | $0.00 | |
| G8427 | Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | 0% | 12,942 | $0.00 |
| 3077F | 0% | 829 | $0.00 | |
| 1160F | 0% | 42 | $0.00 | |
| 3725F | 0% | 123 | $0.00 | |
| G8431 | Screening for depression is documented as being positive and a follow-up plan is documented | 0% | 171 | $0.00 |
| 99072 | 0% | 35 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialALLAM, AZMY (PRESIDENT & CEO)